[15] Zoccali C, Bellizzi V, Minutolo R, Mallamaci F, Conte G, De Nicola L. The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1-3a CKD patients. Clin Kidney J. 2023;16(12):2309-2313. Published 2023 Jul 18. doi:10.1093/ckj/sfad...
临床治疗高磷血症一般遵循“3D原则”,即通过Diet(饮食)、Dialysis(透析)、Drug(药物)调整策略,综合控制高磷血症[12,13]。 1.限磷饮食 减少饮食中磷的摄入对防治 CKD 患者高磷血症非常重要,限磷饮食具有减缓 CKD 患者的肾性骨病进展、纠正电解质代谢异常、降低尿白蛋白排泄和心脑血管发生风险等益处,是常用的降磷...
[15] Zoccali C, Bellizzi V, Minutolo R, Mallamaci F, Conte G, De Nicola L. The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1-3a CKD patients. Clin Kidney J. 2023;16(12):2309-2...
Congestive heart failure, coronary artery disease, stroke or peripheral vascular disease frequency was lower than 10% The prevalence of eGFR < 60 ml/min x 1.73 m(2) was: stage 3 (30-59 ml/min/1.73 m(2)) 19.7%; stage 4 (15-29 ml/min/1.73 m(2)) 1.2%; stage 5 no dialysis (...
Stage1 肾脏损害，肾功能正常或轻度下降 Stage2 肾脏损害合并肾功能轻度下降 Stage3Stage4 肾功能中度下降肾功能严重下降 Stage5 肾衰竭 GFR130 90 60 30 15 0 US患病率 营养不良(PEW)3.1% 4.1% 7.6% 18%–48% 0.5% Upto75% PEW,蛋白质-能量消耗(尿毒症营养不良)USRDS2009AnnualDataReportStrattonJD,...
[15] Zoccali C, Bellizzi V, Minutolo R, Mallamaci F, Conte G, De Nicola L. The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1-3a CKD patients. Clin Kidney J. 2023;16(12):2309-2313. Published 2023 Jul 18. doi:10.1093/ckj/sfad...
The efficacy and safety of protein-restricted diets in chronic kidney disease (CKD) is still a matter of debate. However, several studies have clearly demonstrated the beneficial effects of such diets on the outcome of patients with stage 3-4 CKD. This point has been confirmed by 4 recent st...
[1]. Hill KM, Martin BR, Wastney ME et al. Oral calcium carbonate affects calcium but not phosphorus balance in stage 3–4 chronic kidney disease. Kidney Int 2013; 83:959–966. [2]. 王建枝,等;《病理生理学》,第九版,人民卫生出版社,2018. ...
. Thus, future CKD nutrition guidelines should more clearly encourage patients with mild- to moderate CKD (i.e., CKD stage 1–3) to increase dietary intake of fiber and potassium. Although the CKD guidelines give most attention to restriction of dietary intake of sodium and total protein, ...
From December 2007 to January 2013, all CKD patients (stages 4/5; progressive stage 3) without contraindications (malnutrition, short life expectancy), were offered two main LPDs (proteins 0.6 g/kg daily): Vegan supplemented (LPD-KA) or with "aproteic" commercial food (LPD-ACF). LPDs ...